CONMED Appoints John Gallagher As New CFO To Succeed Todd Garner

June 18, 2026 — 04:12 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - CONMED Corporation (CNMD), a medical technology company, announced the appointment of John E. Gallagher as Chief Financial Officer (CFO), effective July 15, 2026. He will succeed current CFO Todd Garner.

Garner will remain at the company in an advisory capacity till November 2, 2026.

Gallagher brings more than 30 years of experience in corporate finance across public healthcare and industrial companies to the job, serving as CFO of Certara, Inc. since 2023, and formerly at Cue Health Inc. from 2021 to 2023. He previously held the position of Senior Vice President, Corporate Treasurer, and Chief Financial Officer of Becton, Dickinson & Co. (BD), facilitating two acquisitions during his tenure.

CNMD closed Wednesday's trade at $32.11, down 7.12%.

For more such biotechstock news visit rttnews.com.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

CONMED Appoints John Gallagher As New CFO To Succeed Todd Garner

Tags

Latest Articles